NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/07/2026
Voltar para busca
Dado oficial do USPTO
IT PHARMA INNOVATING TECHNOLOGY PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
09/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
3, 5
Data de depósito
06/06/2022
Data de registro
23/07/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/07/2024
Última transação
09/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
87
Localização do titular
ES
Examinador
PARKS, KIMBERLY L
Unidade examinadora
M30
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the designation "IT PHARMA INNOVATING TECHNOLOGY PHARMA" arranged on two lines. On the upper line "IT" with gray capital letters and "PHARMA" in red and lowercase letters, except for the first letter "P" which is capitalized. On the bottom line, "INNOVATING TECHNOLOGY PHARMA" with gray capital letters and in a smaller size.
Titulares e representantes
Titulares
INSTITUTO DE TECNOLOGIA Y ESTETICA PHARMA, S.L.
Representantes
Jesus Sanchelima, Esq. Sanchelima & Associates, P.A.
Classificação técnica
Classes Nice
Classe 3Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 3
Cosmetics; non-medicinal toiletries; essential oils; non-medicinal hair lotions; cosmetic lotions for skin care; non-medicated essences for skin care; non-medicated preparations for skin care; beauty masks; body mask lotions for cosmetic use; skin care creams other than for medical use; tissues impregnated with cosmetic preparations; cosmetic preparations for slimming; cosmetic preparations for topical use; cosmetics for wrinkle treatment
Classe 5
Sanitary preparations for medical use; medical productsliquid pharmaceutical treatments for acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; leaflet pharmaceutical treatments for acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; medicated cosmetic solutions in ampoules for acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; medicated cosmetic solutions in vials for acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; pharmaceutical preparations and substances for treating or prevention of acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; sanitary preparations for medical purposesproducts thereofliquid treatments for acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; leaflet treatments for acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; antioxidant solution in spray being food supplements; chemical preparations for sanitary use; medicinal hair lotions; injectable pharmaceutical products for treating or prevention of acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; injectable sanitary preparations products for medical use; medicinal creams for skin care; medicinal lotions for skin care; pharmacological pharmaceutical preparations for skin care; medical and pharmaceutical preparationsfor application by means of medical devicesfor treating or prevention of acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; pharmaceutical products for treating or prevention of acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; dietetic substances in the nature of liquid treatmentsleaflet treatmentsmedicated cosmetic solutions in ampoulesmedicated cosmetic solutions in vialsantioxidant solution in spray for medical use; dietetic foods for medical use; food for babies; dietetic supplements for humans.
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
29/03/2025
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
27/01/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
27/01/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/10/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
23/07/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
23/07/2024
GPNX
NOTIFICATION PROCESSED BY IB
07/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/05/2024
PUBO
PUBLISHED FOR OPPOSITION
07/05/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/04/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/04/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
01/04/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/04/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
01/04/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/04/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
25/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/03/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
15/03/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/03/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/03/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/12/2023
GNFR
FINAL REFUSAL E-MAILED
07/12/2023
CNFR
FINAL REFUSAL WRITTEN
07/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/12/2023
RFNT
REFUSAL PROCESSED BY IB
26/06/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/06/2023
RFRR
REFUSAL PROCESSED BY MPU
06/06/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/04/2023
CNRT
NON-FINAL ACTION WRITTEN
07/04/2023
DOCK
ASSIGNED TO EXAMINER
21/03/2023
MAFR
APPLICATION FILING RECEIPT MAILED
04/10/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/09/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/09/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace IT PHARMA INNOVATING TECHNOLOGY PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.